KPT — KP Tissue Balance Sheet
0.000.00%
Last trade - 00:00- CA$108.64m
- CA$108.64m
Annual balance sheet for KP Tissue, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Total Receivables | 1.99 | 2.37 | 2.44 | 1.8 | 1.8 |
| Total Current Assets | 1.99 | 2.37 | 2.44 | 1.8 | 1.8 |
| Long Term Investments | |||||
| Total Assets | 80.7 | 81.7 | 70.6 | 71.3 | 71.6 |
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.04 | 1.96 | 2.25 | 1.8 | 1.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 4.85 | 7.68 | 2.25 | 1.8 | 1.8 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 75.9 | 74 | 68.4 | 69.5 | 69.8 |
| Total Liabilities & Shareholders' Equity | 80.7 | 81.7 | 70.6 | 71.3 | 71.6 |
| Total Common Shares Outstanding |